Antigenic properties of Bioplast

Area of Science:

• Biomaterials Science
• Immunology
• Medical Device Research

Background:

• Bioplast fibrin products are used in clinical applications.
• Heat treatment is employed to reduce the antigenicity of biomaterials.
• Previous studies suggested complete elimination of fibrin antigenicity via heat treatment.

Purpose of the Study:

• To investigate the influence of heat treatment on the antigenicity of human Bioplast fibrin powder and plates.
• To determine if heat treatment effectively eliminates the antigenic properties of fibrin biomaterials.

Main Methods:

• Experimental study involving subcutaneous injection and implantation of untreated and heat-treated human fibrin Bioplast products in rabbits.
• Administration of incomplete Freund's adjuvant with fibrin samples.
• Booster dose given 8 weeks post-initial exposure.
• Sera analysis for precipitating antibodies using the Ouchterlony double diffusion technique.

Main Results:

• Precipitating antibodies were detected in rabbits injected or implanted with heat-treated Bioplast fibrin products.
• Contrary to previous findings, heat treatment did not fully eliminate the antigenicity of the tested fibrin biomaterials.
• The study challenges the claim that all fibrin antigenic properties are eliminated by heat treatment.

Conclusions:

• Heat treatment may not completely abolish the antigenic properties of human Bioplast fibrin.
• The potential for sensitization in humans exists, even with heat-treated fibrin products.
• Clinical use of Bioplast fibrin powder and plates may necessitate the exclusive use of human fibrin to mitigate sensitization risks.